Clinical Trial Update: A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

View source ↗

Summary

A German real-world study evaluating persistence on Upadacitinib versus TNF inhibitors in adults with moderate-to-severe rheumatoid arthritis, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TNF inhibitors (class)
• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Moderate to Severe Rheumatoid Arthritis | Status: RECRUITING